1
Who we see
Children, teens and young adults through age 26 with weight, metabolic, growth, pubertal, thyroid or PCOS concerns.
See referral guidanceFor referring clinicians
Evidence for informed referrals and ongoing care
Find key guidance for pediatric weight and endocrine care, practical referral information and resources to share with patients.
Referral essentials
A clear path for your patient
2
What to send
Include the clinical question and available growth records, relevant notes, labs and medicines. Send what you have.
Refer online, by fax or phone3
What happens next
We contact the patient or family to schedule and send visit notes back to the referring clinician.
How our care worksSelected primary evidence
Useful findings, with the context that matters
Use these summaries to locate the original guidance and research. Individual assessment and current prescribing information guide treatment decisions.
Clinical guideline · AAP 2023
Whole-person obesity care
Children and adolescents with overweight or obesity
The guideline supports family-centered care, evaluation of related health concerns and collaborative goals that extend beyond BMI.
Clinical context
Read the AAP guidelineUse growth, medical and psychosocial context to guide care. A guideline citation alone does not establish a program’s treatment intensity.
Recommendation · USPSTF 2024
Behavioral treatment intensity
Ages 6+ with BMI at or above the 95th percentile
Comprehensive behavioral interventions with 26 or more contact hours are recommended to achieve benefit.
Clinical context
Read the USPSTF recommendationTreatment content and contact time matter when comparing programs or referring for intensive support.
Randomized trial · STEP TEENS 2022
Semaglutide in adolescents
201 participants, ages 12 to under 18; 68 weeks
Mean BMI changed by −16.1% with semaglutide and +0.6% with placebo; both groups received lifestyle intervention.
Clinical context
Read the STEP TEENS studyDiscuss benefits and adverse effects together. These are trial results, not EndoMD outcomes or a prediction for an individual.
Evidence-based recommendations · 2025
PCOS assessment in adolescence
Adolescents with menstrual or androgen-related concerns
Diagnosis considers menstrual irregularity and hyperandrogenism after excluding other causes; timing after menarche matters.
Clinical context
Read the adolescent PCOS recommendationsAdolescent criteria differ from adult criteria. Ultrasound or AMH alone should not drive adolescent diagnosis.
Good to know
Referral questions
Can I refer by phone?
Yes. Call (571) 480-6053, use the online referral form or fax the referral and available records to (804) 660-6321.
Will I receive notes after the visit?
Yes. We send visit notes to the referring clinician so you can stay informed about the assessment and next steps.
Evidence & use
Go directly to the source
These summaries support professional learning and patient conversations. Read our medical disclaimer.
Have a patient in mind?
Refer online, by fax or by phone. We contact the patient or family to schedule and send visit notes back to you.
Refer a patient
(571) 480-6053